These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Pharmacokinetics of furosemide in anephric patients and in normal subjects. Andreasen F; Hansen HE; Mikkelsen E Eur J Clin Pharmacol; 1978 Mar; 13(1):41-8. PubMed ID: 639832 [TBL] [Abstract][Full Text] [Related]
67. Role of atriopeptin in blood pressure regulation. Blaine EH Am J Med Sci; 1988 Apr; 295(4):293-8. PubMed ID: 2966580 [No Abstract] [Full Text] [Related]
68. Rate of clearance of interleukin-1 from the blood of normal and nephrectomized rats. Kampschmidt RF; Jones T Proc Soc Exp Biol Med; 1985 Oct; 180(1):170-3. PubMed ID: 3875860 [TBL] [Abstract][Full Text] [Related]
69. De novo biosynthesis of plasminogen in the anephric rat. Siefring GE; Castellino FJ J Appl Physiol; 1975 Jan; 38(1):114-6. PubMed ID: 1110227 [TBL] [Abstract][Full Text] [Related]
70. A heart-adipose tissue connection in the regulation of energy metabolism. Collins S Nat Rev Endocrinol; 2014 Mar; 10(3):157-63. PubMed ID: 24296515 [TBL] [Abstract][Full Text] [Related]
71. Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat. Moss NG; Riguera DA; Fellner RC; Cazzolla C; Goy MF Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1433-42. PubMed ID: 20861080 [TBL] [Abstract][Full Text] [Related]
72. Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig. Hermel M Inflammopharmacology; 1998; 6(2):159-78. PubMed ID: 17694372 [TBL] [Abstract][Full Text] [Related]
73. Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance. Lang CC; Moreland T; Choy AM; Pringle TH; McNeill GP; Struthers AD Eur J Clin Pharmacol; 1995; 48(6):429-34. PubMed ID: 8582459 [TBL] [Abstract][Full Text] [Related]
74. Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics. Tan AC; Russel FG; Thien T; Benraad TJ Clin Pharmacokinet; 1993 Jan; 24(1):28-45. PubMed ID: 8448971 [TBL] [Abstract][Full Text] [Related]
75. Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site. Vanneste Y; Michel A; Dimaline R; Najdovski T; Deschodt-Lanckman M Biochem J; 1988 Sep; 254(2):531-7. PubMed ID: 2972276 [TBL] [Abstract][Full Text] [Related]
76. Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors. Kramer HJ; Lichardus B Klin Wochenschr; 1986 Aug; 64(16):719-31. PubMed ID: 2945041 [TBL] [Abstract][Full Text] [Related]
77. The behaviorally active peptide ACTH 4-10: measurement in plasma and pharmacokinetics in man. Bickel U; Born J; Fehm HL; Distler M; Voigt KH Eur J Clin Pharmacol; 1988; 35(4):371-7. PubMed ID: 2848706 [TBL] [Abstract][Full Text] [Related]
78. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543 [TBL] [Abstract][Full Text] [Related]
79. Rapid receptor-mediated catabolism of 125I-atrial natriuretic factor by vascular endothelial cells. Johnson GR; Arik L; Pitts BJ; Foster CJ Biochem J; 1990 Jun; 268(3):771-6. PubMed ID: 2163622 [TBL] [Abstract][Full Text] [Related]